HealthPhoto: Amar UjalaSupreme Court Questions High Cancer Drug Prices, Proposes Trade Margin Cap
The Supreme Court questioned why a cancer drug costing ₹78 has an MRP of ₹2,850, highlighting concerns over high prices. The Centre plans to cap trade margins on cancer drugs at 30 percent. The court also called for a broader review of drug prices to ensure affordability and regulate excessive markups in the pharmaceutical sector.
Amar Ujala·



